IBA develops radiation-based pharmaceuticals used in the evaluation of oncology, neurology and cardiology diseases.
IBA is a worldwide leader in the design of cyclotron solutions, and the production and distribution of radiopharmaceuticals used in thousands of hospitals around the world.
The healthcare industry is using molecular imaging to detect disease earlier and treat it more effectively, with measurable improvements every day. IBA Molecular is part of this progress, developing the tracers and equipment of tomorrow that will turn the hope of personalized medicine into reality… because everyone deserves a unique answer.
Cyclone 11®: Limited space, Unlimited functionality
Cyclone® 18/9: Moving Ahead, Delivering More
Cyclone® 18 Twin: Double source - Double life
IBA Molecular: We do everything to deliver what really counts
Nirta® Target technology: Complete target range for your extended needs
Synthera®: Chemistry Straightforward
Tracer catalog: A complete palette in nuclear medicine
© IBA 2010 | All rights reserved | Disclaimer | Privacy Policy | 
We Protect, Enhance, and Save lives
HU Chunlin |
LI Chen |
XIE Jia Ying |
Turning ideas into reality
From initial project to realization:
IBA Financial Solutions turn your ideas into reality through our business know-how, experience in export and project finance coupled with excellent network of financial partners. IBA can definitely help customers set up a tailor-made financing solution.
We have been awarded the ‘PPP’ deal of the year (EMEA) by finance magazine and ‘Healthcare Deal of the year 2006’ by Euromoney magazine. In 3 years, we have developed financing solutions for: 7 proton therapy centers projects, 2 projects related to FDG production centers, 10 cyclotron installation projects and several turnkey industrial sterilization facilities.
